Pacira BioSciences Ownership | Who Owns Pacira BioSciences?


OverviewForecastRevenueFinancialsChartTranscripts

Pacira BioSciences Ownership Summary


Pacira BioSciences is owned by 109.63% institutional investors, 1.75% insiders. Blackrock is the largest institutional shareholder, holding 17.34% of PCRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.02% of its assets in Pacira BioSciences shares.

PCRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPacira BioSciences109.63%1.75%-11.38%
SectorHealthcare Stocks 50.51%12.37%37.12%
IndustrySpecialty & Generic Drug Manufacturers Stocks35.91%15.07%49.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock8.01M17.34%$229.08M
Blackrock funding, inc. /de6.71M16.57%$170.13M
Vanguard group4.81M10.93%$124.56M
Doma perpetual capital management2.78M6.87%$70.47M
Dimensional fund advisors lp2.10M5.20%$53.36M
State street2.06M5.09%$52.26M
D. e. shaw1.95M4.82%$49.48M
Renaissance1.73M4.29%$43.99M
Vanguard capital management1.69M4.18%$42.92M
Goldman sachs group1.53M3.77%$38.74M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Doma perpetual capital management2.78M16.36%$70.47M
Gagnon advisors352.64K5.92%$8.95M
Sio capital management455.50K3.53%$13.03M
Gagnon securities608.62K3.04%$15.44M
Bridge city capital312.30K1.81%$7.92M
Lion point capital, lp13.50K1.64%$342.50K
Coppell advisory solutions16.000.46%$5.59M
Easterly investment partners337.02K0.44%$8.55M
Hillsdale investment management362.70K0.21%$9.20M
Milestone asset management51.96K0.21%$1.32M

Top Buyers

HolderShares% AssetsChange
Sixth street partners management company690.79K0.00%690.79K
Adage capital partners gp410.00K0.02%410.00K
Ubs group920.22K0.00%358.18K
Sio capital management455.50K3.53%343.50K
Nuveen asset management625.92K0.00%327.75K

Top Sellers

HolderShares% AssetsChange
Frontier capital management---1.84M
Stephens investment management group---1.37M
Clearbridge investments---1.17M
Point72 asset management---1.08M
Polar capital---910.46K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company690.79K0.00%690.79K$17.53M
Adage capital partners gp410.00K0.02%410.00K$10.57M
Marshall wace, llp129.35K0.00%129.35K$3.28M
Man group125.37K0.01%125.37K$3.18M
Axa investment managers117.28K0.01%117.28K$3.02M

Sold Out

HolderChange
Dunhill financial-1.00
Ameritas advisory services-2.00
Annis gardner whiting capital advisors-4.00
Prairieview partners-5.00
Dinuzzo private wealth-6.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20262534.12%44,358,2211.77%1091.04%118-2.48%842.44%
Mar 31, 2026128-51.88%14,147,460-70.02%330.29%68-50.37%36-61.29%
Dec 31, 2025195-19.42%35,011,226-27.00%790.71%104-1.89%62-34.74%
Sep 30, 2025127-44.30%24,235,325-47.07%530.53%56-51.30%48-31.43%
Jun 30, 2025233-3.32%50,471,236-0.11%1110.93%114-1.72%75-6.25%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF2.40M6.02%1.65K
Vanguard Morn Total Stk Mkt Idx Investor1.20M3.05%-53.40K
Vanguard Total Stock Mkt Idx Inv1.20M3.05%-53.40K
Vanguard MStar Total Stk Mkt Idx Invest1.20M3.01%-
Vanguard US Total Market Shares ETF1.37M2.97%-
Delaware Small Cap Core I1.26M2.74%-18.77K
iShares Russell 2000 ETF1.01M2.54%-17.95K
Vanguard Small Cap Index858.33K2.16%3.61K
Impax Small Cap Institutional750.03K1.88%-
Impax US Small Cap Strategy Composite750.03K1.88%-

Recent Insider Transactions


DateNameRoleActivityValue
Aug 17, 2026SLONIN JONATHAN Chief Medical OfficerSell$70.62K
Jun 11, 2026RIKER LAUREN Senior Vice President, FinanceSell$143.70K
Jun 04, 2026WILLIAMS KRISTEN Chief Administrative OfficerSell$228.47K
Apr 23, 2026Cross Shawn Chief Financial OfficerSell$325.60K
Apr 20, 2026Cross Shawn Chief Financial OfficerSell$193.93K

Insider Transactions Trends


DateBuySell
2026 Q3-1
2026 Q2-5
2026 Q1-5
2025 Q4-4
2025 Q3-2

PCRX Ownership FAQ


Who Owns Pacira BioSciences?

Pacira BioSciences shareholders are primarily institutional investors at 109.63%, followed by 1.75% insiders and -11.38% retail investors. The average institutional ownership in Pacira BioSciences's industry, Specialty & Generic Drug Manufacturers Stocks, is 35.91%, which Pacira BioSciences exceeds.

Who owns the most shares of Pacira BioSciences?

Pacira BioSciences’s largest shareholders are Blackrock (8.01M shares, 17.34%), Blackrock funding, inc. /de (6.71M shares, 16.57%), and Vanguard group (4.81M shares, 10.93%). Together, they hold 44.84% of Pacira BioSciences’s total shares outstanding.

Does Blackrock own Pacira BioSciences?

Yes, BlackRock owns 17.34% of Pacira BioSciences, totaling 8.01M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 229.08M$. In the last quarter, BlackRock increased its holdings by 101.67K shares, a 1.29% change.

Who is Pacira BioSciences’s biggest shareholder by percentage of total assets invested?

Doma perpetual capital management is Pacira BioSciences’s biggest shareholder by percentage of total assets invested, with 16.36% of its assets in 2.78M Pacira BioSciences shares, valued at 70.47M$.

Who is the top mutual fund holder of Pacira BioSciences shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Pacira BioSciences shares, with 6.02% of its total shares outstanding invested in 2.4M Pacira BioSciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools